MedPath

TOBREX

Approved
Approval ID

b1d58360-96b4-4d23-82aa-3e4872dc0136

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 19, 2010

Manufacturers
FDA

STAT RX LLC USA

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TOBRAMYCIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-225
Application NumberNDA050555
Product Classification
M
Marketing Category
C73594
G
Generic Name
TOBRAMYCIN
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateNovember 19, 2010
FDA Product Classification

INGREDIENTS (4)

TOBRAMYCINActive
Quantity: 3 mg in 1 g
Code: VZ8RRZ51VK
Classification: ACTIB
petrolatumInactive
Code: 4T6H12BN9U
Classification: IACT
mineral oilInactive
Code: T5L8T28FGP
Classification: IACT
chlorobutanolInactive
Code: HM4YQM8WRC
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TOBREX - FDA Drug Approval Details